- Coordinator
- Fox Biosystems NV, Belgium
- Runs
- 1 July 2023 to 30 June 2025
- Status
- Ended early
- EU funding
- €2.5m
- Total cost
- €3.6m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190154762
What the project is doing
In the project's own words, from its summary on CORDIS.
The Extracellular vesicles (EV) field is growing due to increased interest in their roles in diagnostics and therapeutics. Current methods to purify and quantify EV’s take a long time, introduce a bias, are costly and imprecise, thereby hampering advancement in the EV R&D field, while the lack of methods to quantify EVs directly in crude samples restricts applications in diagnostic and bioprocessing. FOX has established a breakthrough label-free technology in a fiber-optic concept in an automated platform that allows biomolecular interaction research of biologicals.
The FOx affinity isolation and simultaneous quantification with a sensor dip probe is a new, selective (no bias), automated (scalable 4x), faster (time/24) and specific (purity >95%) method that allows accurately quantifying EV directly from crude samples. Moreover, it allows for the first time to release the quantified and specifically selected EV’s for further quantitative content analysis.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Fox Biosystems NV | Diepenbeek | Belgium | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI